en

PRODUCT DETAIL

Montelukast Medreg 10 mg filmom obalené tablety

Code 0523C
MA number 14/0371/16-S
Product Form: tbl flm 20x10 mg (blis.Al/PVC/Al/OPA)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC Leukotriene receptor antagonists
R03DC03 Montelukast
Shelf life: 36
Container: blister Al/PVC/Al/OPA
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.07.2016
Pediatric posology: Yes
SPC: SPC_Montelukast_medreg_12/2023.pdf  
PIL: PIL_Montelukast Medreg_12/2023.pdf  
Safety feature Yes
Data update: 12.02.2021
eu-flag.png sk-flag.png